GlassScriptPhysician profile
Shashi Reddy
NPI 1588632335
$2,988.21
in general payments reported to CMS, 2019-2025
27 companies · $433 in 2025
The $433 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $212 · 2021: $426 · 2022: $399 · 2023: $502 · 2024: $547 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,482.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $378.39 | 2019-2025 | Xtandi |
| Endo Pharmaceuticals INC. | $340.25 | 2019-2024 | Xiaflex |
| Coloplast Corp | $250.43 | 2020-2024 | Speedicath |
| Blue Earth Diagnostics | $238.16 | 2021-2025 | Posluma |
| Abbvie INC. | $193.15 | 2020-2025 | |
| Pfizer INC. | $177.28 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $133.66 | 2019-2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $117.89 | 2023-2024 | Orgovyx |
| Urogen Pharma, INC. | $101.79 | 2021-2025 | Jelmyto |
| Olympus America INC. | $97.00 | 2019-2022 | |
| Accord Healthcare, INC. | $82.49 | 2023-2024 | |
| Endo USA, INC. | $82.31 | 2024-2025 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $80.71 | 2019-2023 | Provenge |
| Progenics Pharmaceuticals, INC. | $79.90 | 2023-2024 | Pylarify |
| Procept Biorobotics Corporation | $72.69 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $71.78 | 2025 | Illuccix |
| Boston Scientific Corporation | $70.88 | 2019 | |
| Myovant Sciences INC. | $64.51 | 2021-2022 | |
| Immunitybio, INC. | $61.75 | 2024-2025 | |
| Allergan, INC. | $61.74 | 2019-2021 | |
| Janssen Biotech, INC. | $61.67 | 2019-2025 | Erleada |
| 180 Medical, INC. | $53.39 | 2022 | |
| Smith+Nephew, INC. | $31.36 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.30 | 2024 | |
| Myriad Genetic Laboratories, INC. | $25.10 | 2022 | |
| Teleflex LLC | $19.04 | 2025 | Barrigel |
| Avadel Specialty Pharmaceuticals, LLC | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shashi Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.